longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Perpetua Resources

PPTA

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI
  • Weekly Recap | Perpetua Resources +1.08%, consensus target above spot

    Weekly Review·Sep 26 at 06:55 AM
    PPTA-7.11%
  • JPMorgan Chase launches "America First" fund, with the first investment directed towards "antimony"

    Wallstreetcn·Oct 28, 2025 at 03:52 AM
    - Morgan Stanley has invested $75 million in Perpetua Resources, marking the first deployment of its $10 billion strategic investment fund aimed at supporting critical U.S. sectors. - The investment focuses on antimony mining, a key mineral used in military and technology applications, and reflects confidence in the commercial viability of the Stibnite gold-antimony project. - This move, alongside Agnico Eagle Mines' $180 million investment, underscores the importance of commercial returns in the fund's strategy, as emphasized by CEO Jamie Dimon.
    PPTA-7.11%JPM-1.89%
  • Betting on gold for 15 years, Paulson achieved great success; he didn't buy gold bars, but rather gold mines

    Wallstreetcn·Apr 28, 2025 at 12:20 AM
    - Billionaire hedge fund manager John Paulson is achieving significant success with his long-term gold investments, following his fame from shorting the U.S. housing market 15 years ago. - Paulson's strategy involves investing in gold mining companies rather than holding physical gold, with a reported investment value of approximately $840 million in listed mining stocks, all of which saw gains last year. - Recently, he invested $800 million for a 40% stake in the Donlin gold project in Alaska, which has substantial potential but faces significant development challenges and risks.
    PPTA-7.11%AEM-5.31%